TrademarkDir
RENALYTIXAI
LIVE

Serial Number

88956754

Owner

Renalytix AI, Inc.

Attorney

John Maldjian

First Use Date

Jun 9, 2021

Filing Date

Jun 9, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RENALYTIXAI Trademark

Serial Number: 88956754 • Registration: 7081093

RENALYTIXAI is a trademark filed by Renalytix AI, Inc. on June 9, 2020. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Renalytix AI, Inc. (23 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 03

Trademark Details

Filing Date

June 9, 2020

Registration Date

June 13, 2023

First Use Anywhere

June 9, 2021

First Use in Commerce

June 9, 2021

Published for Opposition

October 20, 2020

Goods & Services

Blood test collection kit comprised of blood collection bag, holder for medical sample tubes, vials, and test trips, and medical sample tubes, vials, and test strips for predicting, identifying and determining the presence and stage of kidney diseases

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 14, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 14, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 14, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 14, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 14, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 13, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 11, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 10, 2023 CNPR
EXAMINER'S AMENDMENT ENTERED
May 10, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 10, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 10, 2023 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
May 10, 2023 SNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jan 24, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 24, 2023 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Jan 5, 2023 SUPC
SOU EXTENSION 4 GRANTED
Jan 5, 2023 EX4G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 5, 2023 AITU
USE AMENDMENT FILED
Dec 15, 2022 IUAF
SOU EXTENSION 4 FILED
Dec 15, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 15, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Dec 15, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2022 EXRA
SOU EXTENSION 3 GRANTED
Jun 14, 2022 EX3G
SOU EXTENSION 3 FILED
Jun 14, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 14, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 16, 2021 EXRA
SOU EXTENSION 2 GRANTED
Dec 14, 2021 EX2G
SOU EXTENSION 2 FILED
Dec 14, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 14, 2021 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 12, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 12, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 12, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 12, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 16, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jun 14, 2021 EX1G
SOU EXTENSION 1 FILED
Jun 14, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 14, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 15, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 20, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 20, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 30, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 15, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 15, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 15, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 15, 2020 CNEA
ASSIGNED TO EXAMINER
Sep 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 6, 2020 NWOS
NEW APPLICATION ENTERED
Jun 12, 2020 NWAP

Related Trademarks

More from this Owner

#UNSILENTCKD

#UNSILENTCKD

#UNSILENTCKD

#UNSILENTCKD

KIDNEVITY

KIDNEVITY

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.

NOT JUST ANALYTICS. IT'S BIOPROGNOSIS.

KIDNEVITY

KIDNEVITY